Navigation Links
European Multidisciplinary Conference on Thoracic Oncology
Date:3/4/2009

The European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS) are pleased to announce the first European Multidisciplinary Conference on Thoracic Oncology (EMCTO).

This meeting will provide a comprehensive update and a multidisciplinary perspective of state-of-the-art on the prevention, screening, diagnosis, and treatment of chest tumors, including results of translational research. It will facilitate scientific and clinical exchange, with the aim of promoting an integrated approach to diagnosis, treatment and management of thoracic cancers.

Thoracic cancers are globally recognized as a major cause of mortality. Combating their causes, developing better methods for early detection, advancing research, and improving treatments, require the collaboration of many research and clinical specialties.

Organized in partnership between the European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS), the conference is designed to provide healthcare professionals with a comprehensive update and a multidisciplinary perspective of state-of-the-art management of patients with thoracic malignancies, including the role of new technologies and the necessary collaboration between various medical specialties.

By bringing together authoritative European partners in thoracic oncology, EMCTO represents an excellent opportunity to promote an integrated approach to diagnosis and treatment of chest tumors and to strengthen European cooperation and scientific exchange .

Meeting highlights:

  • New developments in understanding lung cancer biology
  • Prognostic and predictive factors in non-small-cell lung cancer
  • Critical appraisal of imaging tools in thoracic oncology
  • Individualized staging: practical implications
  • Heterogeneity of locally advanced lung cancer and its implications for treatment
  • Chemoradiotherapy and new developments in radiotherapy
  • Neuroendocrine tumors, mesothelioma and thymoma
  • Individualized therapy based on tumor features
  • Elderly and co-morbid patients
  • Future developments in multidisciplinary treatments

Among the top international experts who have contributed to this multidisciplinary conference: Rolf Stahel, Switzerland; Robert Pirker, Austria; David Gandara, US; Enriqueta Felip, Spain; Giorgio Scagliotti, Italy; Franoise Mornex, France; Paris Kosmidis, Greece; Michael Cullen, UK; Jean-Paul Sculier, Belgium; Cesare Gridelli, Italy; Walter Weder, Switzerland

Meeting venue

The European Multidisciplinary Conference in Thoracic Oncology (EMCTO) will take place at the Palazzo dei Congressi, Lugano.

Services for media representatives

A fully equipped press room will be in operation at the conference with Internet access and telephone lines for registered reporters. You will have access to all the scientific sessions and the possibility to schedule one-on-one interviews with top speakers and presenters of the studies, both in presence and remotely. Please contact the ESMO Communication Dept. at media@esmo.org to already find out about the preliminary timetable or to book a telephone hook up. The conference full program is available at http://www.esmo.org/newsroom/events/

Media registration

To register for the conference as a media representative, please visit http://www.esmo.org/newsroom/events/ and send the Complimentary Media Registration form to the ESMO Communication Department.

Accommodation

For hotel reservation, please visit: http://www.esmo.org/events/lung-2009/book-hotel.html


'/>"/>
Contact: ESMO Press Office
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related biology news :

1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
2. 2 French scientists win European award for communication
3. Three-way mating game of North American lizard found in distant European relative
4. European lead in reading past climates from ice cores
5. Hot spots the key to controlling European carp in Australia
6. IdentiPHI Opens Paris Office to Boost European Sales and Support
7. European Union forests expanding, absorbing carbon at surprisingly high rate: study
8. First European Lung Cancer Conference
9. ESFs European ice core project EPICA receives prestigious Descartes Prize
10. European membrane expertise to focus on new treatments for human diseases
11. European light research opens door for optical storage and computing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):
(Date:5/26/2016)... San Diego, CA (PRWEB) , ... May 26, ... ... assay development and manufacturing company, today announced several positive developments that position the ... As a result of the transaction, Craig F. Kinghorn has been appointed ...
(Date:5/25/2016)... ... May 25, 2016 , ... Founder of the Fitzmaurice Hand ... and surgery of the hand by the National Board of Physicians and Surgeons, ... and beyond in his pursuit of providing the most comprehensive, effective treatment for ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company ... granted the company’s orphan drug designation request covering BHV-4157 for the treatment of ... the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that ...
(Date:5/23/2016)... ... May 23, 2016 , ... The need for blood donations in South Texas and across ... South Texas Blood & Tissue Center, blood donations are on the decline. In fact, donations ... are down 21 percent in South Texas in the last four years alone. , There ...
Breaking Biology Technology: